MeSH Review:
Cervix Uteri
Wright,
Denny,
Kuhn,
Pollack,
Lorincz,
Acs,
Zhang,
McGrath,
Acs,
McBroom,
Mohyeldin,
Liu,
Lu,
Verma,
Geradts,
Maynard,
Birrer,
Hendricks,
Abbondanzo,
Fong,
Barrett,
Lombardi,
Obermair,
Bancher-Todesca,
Bilgi,
Kaider,
Kohlberger,
Müllauer-Ertl,
Leodolter,
Gitsch,
Sheu,
Lien,
Ho,
Lin,
Chow,
Huang,
Hsu,
Eifel,
Winter,
Morris,
Levenback,
Grigsby,
Cooper,
Rotman,
Gershenson,
Mutch,
Sherwood,
- Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Cappellen, D., De Oliveira, C., Ricol, D., de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J.P., Radvanyi, F. Nat. Genet. (1999)
- Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. Melnick, S., Cole, P., Anderson, D., Herbst, A. N. Engl. J. Med. (1987)
- Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. Robboy, S.J., Noller, K.L., O'Brien, P., Kaufman, R.H., Townsend, D., Barnes, A.B., Gundersen, J., Lawrence, W.D., Bergstrahl, E., McGorray, S. JAMA (1984)
- Cost-effectiveness of combined treatment for endocervical gonorrhea. Considering co-infection with Chlamydia trachomatis. Washington, A.E., Browner, W.S., Korenbrot, C.C. JAMA (1987)
- 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix. Lippman, S.M., Kavanagh, J.J., Paredes-Espinoza, M., Delgadillo-Madrueño, F., Paredes-Casillas, P., Hong, W.K., Massimini, G., Holdener, E.E., Krakoff, I.H. J. Natl. Cancer Inst. (1993)
- Activity of the genital tract and plasma levels of oxytocin and cortisol at the time of mating in the ewe. Garcia-Villar, R., Schams, D., Alvinerie, M., Laurentie, M.P., Toutain, P.L. J. Endocrinol. (1985)
- Vasoactive intestinal polypeptide (VIP) inhibits neurally evoked smooth muscle activity of rat uterine cervix in vitro. Stjernquist, M., Owman, C. Regul. Pept. (1984)
- Lack of evidence for cancer due to use of metronidazole. Beard, C.M., Noller, K.L., O'Fallon, W.M., Kurland, L.T., Dockerty, M.B. N. Engl. J. Med. (1979)
- Relaxin's physiological roles and other diverse actions. Sherwood, O.D. Endocr. Rev. (2004)
- HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Wright, T.C., Denny, L., Kuhn, L., Pollack, A., Lorincz, A. JAMA (2000)
- Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer. Grinstein, E., Wernet, P., Snijders, P.J., Rösl, F., Weinert, I., Jia, W., Kraft, R., Schewe, C., Schwabe, M., Hauptmann, S., Dietel, M., Meijer, C.J., Royer, H.D. J. Exp. Med. (2002)
- Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. Obermair, A., Bancher-Todesca, D., Bilgi, S., Kaider, A., Kohlberger, P., Müllauer-Ertl, S., Leodolter, S., Gitsch, G. J. Natl. Cancer Inst. (1997)
- Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. Omura, G.A., Blessing, J.A., Vaccarello, L., Berman, M.L., Clarke-Pearson, D.L., Mutch, D.G., Anderson, B. J. Clin. Oncol. (1997)
- Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. Whitney, C.W., Sause, W., Bundy, B.N., Malfetano, J.H., Hannigan, E.V., Fowler, W.C., Clarke-Pearson, D.L., Liao, S.Y. J. Clin. Oncol. (1999)
- Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. Bloss, J.D., Blessing, J.A., Behrens, B.C., Mannel, R.S., Rader, J.S., Sood, A.K., Markman, M., Benda, J. J. Clin. Oncol. (2002)
- A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. Omura, G.A., Blessing, J.A., Major, F., Lifshitz, S., Ehrlich, C.E., Mangan, C., Beecham, J., Park, R., Silverberg, S. J. Clin. Oncol. (1985)
- Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy. Thomson, A.J., Lunan, C.B., Ledingham, M., Howat, R.C., Cameron, I.T., Greer, I.A., Norman, J.E. Lancet (1998)
- High-level expression of the retinoic acid receptor beta gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells. Geisen, C., Denk, C., Gremm, B., Baust, C., Karger, A., Bollag, W., Schwarz, E. Cancer Res. (1997)
- Keratin subtypes in carcinomas of the uterine cervix: implications for histogenesis and differential diagnosis. Ivanyi, D., Groeneveld, E., Van Doornewaard, G., Mooi, W.J., Hageman, P.C. Cancer Res. (1990)
- Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics. Presant, C.A., Wolf, W., Albright, M.J., Servis, K.L., Ring, R., Atkinson, D., Ong, R.L., Wiseman, C., King, M., Blayney, D. J. Clin. Oncol. (1990)
- Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. Geradts, J., Maynard, R., Birrer, M.J., Hendricks, D., Abbondanzo, S.L., Fong, K.M., Barrett, J.C., Lombardi, D.P. Am. J. Pathol. (1999)
- Indium-111 labelled monoclonal antibody to placental alkaline phosphatase in in the detection of neoplasms of testis, ovary, and cervix. Epenetos, A.A., Snook, D., Hooker, G., Begent, R., Durbin, H., Oliver, R.T., Bodmer, W.F., Lavender, J.P. Lancet (1985)
- Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Woodworth, C.D., McMullin, E., Iglesias, M., Plowman, G.D. Proc. Natl. Acad. Sci. U.S.A. (1995)
- Abnormal Fhit expression in malignant and premalignant lesions of the cervix. Birrer, M.J., Hendricks, D., Farley, J., Sundborg, M.J., Bonome, T., Walts, M.J., Geradts, J. Cancer Res. (1999)
- Ether a go-go potassium channels as human cervical cancer markers. Farias, L.M., Ocaña, D.B., Díaz, L., Larrea, F., Avila-Chávez, E., Cadena, A., Hinojosa, L.M., Lara, G., Villanueva, L.A., Vargas, C., Hernández-Gallegos, E., Camacho-Arroyo, I., Dueñas-González, A., Pérez-Cárdenas, E., Pardo, L.A., Morales, A., Taja-Chayeb, L., Escamilla, J., Sánchez-Peña, C., Camacho, J. Cancer Res. (2004)
- Cancer and dysplasia of cervix in relation to reduced lymphocytic cortisol metabolism-enhancing effect. Klein, A., Storch, B., Beckerman, A., Meyerson, E., Colev, S., Kaufmann, H., Schachter, A. J. Natl. Cancer Inst. (1984)
- Extra-amniotic prostaglandin E2 and the unfavourable cervix. Shepherd, J., Sims, C., Craft, I. Lancet (1976)
- Oestradiol applied locally to ripen the unfavourable cervix. Gordon, A.J., Calder, A.A. Lancet (1977)
- Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C. Mikami, M., Ezawa, S., Sakaiya, N., Komuro, Y., Tei, C., Fukuchi, T., Mukai, M. Lancet (2000)
- Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. el-Refaey, H., Calder, L., Wheatley, D.N., Templeton, A. Lancet (1994)
- Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Sales, K.J., Katz, A.A., Howard, B., Soeters, R.P., Millar, R.P., Jabbour, H.N., Soeters, R.P. Cancer Res. (2002)
- Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Sheu, B.C., Lien, H.C., Ho, H.N., Lin, H.H., Chow, S.N., Huang, S.C., Hsu, S.M. Cancer Res. (2003)
- Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Acs, G., Zhang, P.J., McGrath, C.M., Acs, P., McBroom, J., Mohyeldin, A., Liu, S., Lu, H., Verma, A. Am. J. Pathol. (2003)
- p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Kessis, T.D., Slebos, R.J., Han, S.M., Shah, K., Bosch, X.F., Muñoz, N., Hedrick, L., Cho, K.R. Am. J. Pathol. (1993)
- Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis. Hill, S.C., Youde, S.J., Man, S., Teale, G.R., Baxendale, A.J., Hislop, A., Davies, C.C., Luesley, D.M., Blom, A.M., Rickinson, A.B., Young, L.S., Eliopoulos, A.G. J. Immunol. (2005)
- Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium. Trowell, J., Peto, R., Smith, A.C. Lancet (1975)
- Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Eifel, P.J., Winter, K., Morris, M., Levenback, C., Grigsby, P.W., Cooper, J., Rotman, M., Gershenson, D., Mutch, D.G. J. Clin. Oncol. (2004)
- Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. Pignata, S., Silvestro, G., Ferrari, E., Selvaggi, L., Perrone, F., Maffeo, A., Frezza, P., Di Vagno, G., Casella, G., Ricchi, P., Cormio, G., Gallo, C., Iodice, F., Romeo, F., Fiorentino, R., Fortuna, G., Tramontana, S. J. Clin. Oncol. (1999)
- Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study. Morris, M., Blessing, J.A., Monk, B.J., McGehee, R., Moore, D.H. J. Clin. Oncol. (2004)